Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trials.
<h4>Background</h4>Benchmarking an observational analysis against a randomized trial can increase confidence in the use of observational data to complement inferences made in trials. Until now, few examples of benchmarking have been within oncology. However, benchmarking trials of a canc...
Saved in:
| Main Authors: | Vanessa Voelskow, Xabier Garcia-Albeniz, Anita Berglund, Maria Feychting, Tobias Kurth, Anthony A Matthews |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-07-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1004661 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of anthracyclines and trastuzumab for breast cancer in women with and without a history of cardiovascular disease in Sweden: a national cross-sectional study
by: Helena Carreira, et al.
Published: (2025-06-01) -
A Target Trial Emulation of the PREDIMED Trial Protocol in Two US Cohorts
by: Octavio Pano Espinola, et al.
Published: (2025-05-01) -
Application of the target trial emulation framework to external comparator studies
by: Kellyn Arnold, et al.
Published: (2024-04-01) -
A curated benchmark dataset for molecular identification based on genome skimming
by: Renata C. Asprino, et al.
Published: (2025-05-01) -
Negative Impact of Olanzapine on ICU Delirium Resolution: An Emulated Clinical Trial
by: Ajna Hamidovic, et al.
Published: (2025-07-01)